Evaluating cell-free RNA extraction platforms for RNA liquid biopsy via nanopore sequencing
RNA liquid biopsies provide systemic insights into health and disease by profiling cell-free RNAs (cfRNAs) secreted into the circulation. While cfRNAs are thought to be short or fragmented, recent efforts using long-read nanopore sequencing have found that thousands of longer, full-length cfRNAs are highly abundant in plasma. However, cfRNA extraction methods have not been rigorously evaluated to assess reproducibility, cfRNA length, and transcriptome complexity. Here we show that extraction workflow is a major source of variation by comparing identical plasma samples across three different cfRNA extraction platforms. While these platforms recover comparable quantities of cfRNA, we perform nanopore sequencing to show that they differ in their cfRNA composition based on read-length distribution and biotype representation. Principal component analysis and hierarchical clustering of variable protein-coding and repeat-derived cfRNAs show that samples tend to cluster based on extraction platform. Robust detection of specific biotypes is contingent on extraction platform, as evidenced by significant enrichment of Alu element- and long noncoding RNA (lncRNA)-derived cfRNAs in some but not all methodologies. Our results reveal that cfRNA extraction platforms influence the composition and complexity of downstream libraries, highlighting the importance of selecting the right platform for profiling disease-relevant biomarkers in RNA liquid biopsy studies.
Authors
- Daniel H. Kim (ORCID: https://orcid.org/0000-0003-0684-6245)
- Connor S Mattingly (ORCID: https://orcid.org/0009-0006-3186-4671)
- Alexander Hill (ORCID: https://orcid.org/0000-0001-8903-0297)
Institutions
- University of California, Santa Cruz (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-20
- DOI
- https://doi.org/10.64898/2026.11.19.767748
- Primary Topic
- Extracellular vesicles in disease
- Type
- preprint